e.g. mhealth
Search Results (1 to 4 of 4 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 2 JMIR Research Protocols
- 1 JMIR Formative Research
- 1 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Many of the countries in the region lack national action plans for AMR, alluding to AMR not being among their health priorities [8]. In contrast, some high-income economies of Europe and America had already instituted various regional and national AMR action plans as early as 2014 [9-12].
JMIR Res Protoc 2024;13:e58116
Download Citation: END BibTex RIS
Antimicrobial resistance (AMR) is a serious public health threat [1]. It involves bacteria becoming resistant to antibiotics, potentially leading to infectious diseases no longer being treatable with antimicrobial agents and is driven by antibiotic use [2,3]. The patient, health care, and economic costs of AMR are significant.
JMIR Form Res 2024;8:e54458
Download Citation: END BibTex RIS
Antimicrobial resistance (AMR) is recognized by the World Health Organization (WHO) as one of the most pressing concerns of our time. Overprescription and incorrect usage of antibiotics have further contributed to the worsening crisis. With deaths attributed to AMR reaching 4.95 million in 2019 [1] and a predicted cumulative global cost of $100 trillion by 2050, it is clear that novel strategies to combat AMR are desperately needed [2,3].
J Med Internet Res 2023;25:e42363
Download Citation: END BibTex RIS
This suggests the potential for use of antibiotics in food-producing animals to be important to address to help curb AMR.
California has a large livestock industry and is one of the leading US producers of beef cattle, broiler chickens, and turkey [12,13]. It is also the most populous US state, with a human population larger than the Netherlands, Denmark, and Sweden combined (countries that lead the European Union science and policy on AMR in livestock [14,15]).
JMIR Res Protoc 2023;12:e45109
Download Citation: END BibTex RIS